• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺肉瘤样癌根治性切除术后的临床病理结局。

Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung.

机构信息

Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, South Korea.

出版信息

Oncology. 2011;81(3-4):206-13. doi: 10.1159/000333095. Epub 2011 Nov 9.

DOI:10.1159/000333095
PMID:22076573
Abstract

OBJECTIVES

Sarcomatoid carcinoma of the lung is a very rare and aggressive subtype of non-small cell lung cancer. We explored the clinicopathologic characteristics and surgical outcome of this tumor.

METHODS

Among 4,212 patients who underwent curative resection for non-small cell lung cancer from September 1994 to December 2009, 99 patients had sarcomatoid carcinoma. Medical records of patients were reviewed retrospectively.

RESULTS

The mean follow-up period was 16.07 months. Thirty-six patients had pathologic stage I disease, and 63 had more advanced disease. Surgery included 2 wedge resections, 67 lobectomies, 17 bilobectomies, and 13 pneumonectomies. There were 90 pleomorphic carcinomas, 6 spindle cell carcinomas, 1 giant cell carcinoma, 1 carcinosarcoma, and 1 pulmonary blastoma. Overall 5-year survival was 54.3%. Forty-three patients experienced recurrence and 42 of these died of the cancer. Pathologic T stage as defined by the 7th TNM staging system was significantly associated with survival and recurrence (p = 0.004 and 0.002, respectively). Mean positron emission tomography uptake was significantly higher than in other types of lung cancer (p < 0.0001).

CONCLUSIONS

Our results implied that surgery for sarcomatoid carcinoma must be carefully planned after extensive preoperative evaluation. Efforts should be made for accurate preoperative histological diagnosis of large peripheral tumor with exceedingly high positron emission tomography uptake.

摘要

目的

肺肉瘤样癌是一种非常罕见且侵袭性强的非小细胞肺癌亚型。我们旨在探究该肿瘤的临床病理特征和手术治疗效果。

方法

1994 年 9 月至 2009 年 12 月,共有 4212 例非小细胞肺癌患者接受了根治性切除术,其中 99 例为肉瘤样癌患者。我们回顾性分析了这些患者的病历资料。

结果

平均随访时间为 16.07 个月。36 例患者为Ⅰ期病理分期,63 例患者为更晚期的病理分期。手术包括 2 例楔形切除术、67 例肺叶切除术、17 例双肺叶切除术和 13 例全肺切除术。90 例为多形性癌、6 例为梭形细胞癌、1 例为巨细胞癌、1 例癌肉瘤和 1 例肺胚细胞瘤。整体 5 年生存率为 54.3%。43 例患者出现复发,其中 42 例患者死于该肿瘤。第 7 版 TNM 分期系统中定义的病理 T 分期与生存和复发显著相关(p = 0.004 和 0.002)。与其他类型肺癌相比,肉瘤样癌的正电子发射断层扫描摄取值显著更高(p < 0.0001)。

结论

我们的研究结果表明,对于肉瘤样癌患者,必须在进行广泛的术前评估后仔细规划手术。对于具有极高正电子发射断层扫描摄取值的大型外周肿瘤,应努力进行准确的术前组织学诊断。

相似文献

1
Clinicopathologic outcomes of curative resection for sarcomatoid carcinoma of the lung.肺肉瘤样癌根治性切除术后的临床病理结局。
Oncology. 2011;81(3-4):206-13. doi: 10.1159/000333095. Epub 2011 Nov 9.
2
Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.非小细胞肺癌根治性放疗(>59 Gy)后挽救性肺切除术:手术及肿瘤学结局
Ann Thorac Surg. 2008 Nov;86(5):1632-8; discussion 1638-9. doi: 10.1016/j.athoracsur.2008.07.042.
3
Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.基于现行分期系统,肿瘤大小对 1A 期非小细胞肺癌解剖性肺切除术后结局的影响。
J Thorac Cardiovasc Surg. 2012 Feb;143(2):390-7. doi: 10.1016/j.jtcvs.2011.10.023. Epub 2011 Dec 9.
4
An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.术前贫血与接受单纯手术治疗的早期非小细胞肺癌患者生存率降低之间的关联。
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43. doi: 10.1016/j.ijrobp.2004.12.038.
5
Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis.肺肉瘤样癌的结局:监测、流行病学和最终结果数据库分析。
Surgery. 2012 Sep;152(3):397-402. doi: 10.1016/j.surg.2012.05.007. Epub 2012 Jun 26.
6
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.非小细胞肺癌根治性放疗(>59 Gy)及同步化疗后的肺切除术
Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085.
7
[Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].基于分期分类的非小细胞肺癌完全手术切除后的预后
Dtsch Med Wochenschr. 2006 Nov 24;131(47):2643-8. doi: 10.1055/s-2006-956268.
8
Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.单中心25年间T4期非小细胞肺癌的初次手术结果:获益值得冒险。
Ann Thorac Surg. 2008 Oct;86(4):1065-75; discussion 1074-5. doi: 10.1016/j.athoracsur.2008.07.004.
9
Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.肿瘤大小对非小细胞肺癌患者预后的影响:肺段切除术作为一种较小切除方式的作用
J Thorac Cardiovasc Surg. 2005 Jan;129(1):87-93. doi: 10.1016/j.jtcvs.2004.04.030.
10
Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.手术病理因素影响ⅠB期(pT2 N0 M0)非小细胞肺癌的长期预后:一种异质性疾病。
J Thorac Cardiovasc Surg. 2009 Aug;138(2):426-33. doi: 10.1016/j.jtcvs.2008.12.035. Epub 2009 Mar 28.

引用本文的文献

1
Pulmonary sarcomatoid carcinoma: A rare case report, diagnostic dilemma and review of literature.肺肉瘤样癌:一例罕见病例报告、诊断困境及文献复习。
Medicine (Baltimore). 2024 Jul 5;103(27):e38797. doi: 10.1097/MD.0000000000038797.
2
Effect of histological subtype on the efficacy of perioperative chemotherapy in pulmonary sarcomatoid carcinoma: a retrospective study based on SEER population.组织学亚型对肺肉瘤样癌围手术期化疗疗效的影响:一项基于监测、流行病学与结果(SEER)数据库人群的回顾性研究
Transl Lung Cancer Res. 2024 Apr 29;13(4):749-762. doi: 10.21037/tlcr-24-41. Epub 2024 Apr 17.
3
F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma.
氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描成像在肺肉瘤样癌中的应用
Front Oncol. 2024 Feb 14;14:1334156. doi: 10.3389/fonc.2024.1334156. eCollection 2024.
4
Individual risk and prognostic value prediction by machine learning for distant metastasis in pulmonary sarcomatoid carcinoma: a large cohort study based on the SEER database and the Chinese population.基于SEER数据库和中国人群的大样本队列研究:机器学习预测肺肉瘤样癌远处转移的个体风险及预后价值
Front Oncol. 2023 Jun 26;13:1105224. doi: 10.3389/fonc.2023.1105224. eCollection 2023.
5
Emerging new evidence for the treatment of pulmonary sarcomatoid carcinoma.肺肉瘤样癌治疗的新出现证据
J Thorac Dis. 2023 Mar 31;15(3):953-955. doi: 10.21037/jtd-22-1775. Epub 2023 Feb 23.
6
Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre.肺肉瘤样癌的特征与临床结局:来自塔塔纪念中心的经验
Ecancermedicalscience. 2022 Aug 8;16:1438. doi: 10.3332/ecancer.2022.1438. eCollection 2022.
7
Pulmonary Carcinosarcoma: A Rare Disease With Challenging Diagnosis and Treatment.肺肉瘤样癌:一种诊断和治疗颇具挑战性的罕见疾病。
Cureus. 2022 Jul 15;14(7):e26901. doi: 10.7759/cureus.26901. eCollection 2022 Jul.
8
Clinicopathological characteristics, survival outcomes and prognostic factors in pleomorphic carcinoma: a SEER population-based study.多形性癌的临床病理特征、生存结果及预后因素:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
BMC Pulm Med. 2022 Mar 31;22(1):116. doi: 10.1186/s12890-022-01915-1.
9
Prognostic significance of preoperative peripheral blood neutrophil to lymphocyte ratio (NLR) in lung sarcomatoid carcinoma.术前外周血中性粒细胞与淋巴细胞比值(NLR)在肺肉瘤样癌中的预后意义
Transl Cancer Res. 2019 Sep;8(5):1826-1833. doi: 10.21037/tcr.2019.08.35.
10
Recurrent spindle cell carcinoma of the lung successfully treated by chemoimmunotherapy.经化学免疫疗法成功治疗的复发性肺梭形细胞癌。
Respirol Case Rep. 2021 May 7;9(6):e00757. doi: 10.1002/rcr2.757. eCollection 2021 Jun.